Felbamate: Consensus of current clinical experience
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology
Reference56 articles.
1. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines;Beghi;Lancet Neurol.,2004
2. Mortality in childhood-onset epilepsy;Berg;Epilepsia,2003
3. Driving in adults with refractory localization-related epilepsy;Berg;Neurology,2000
4. Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures;Bourgeois;Neurology,1993
5. Felbamate: a new antiepileptic drug;Brodie;Lancet,1993
Cited by 96 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Therapeutic drug monitoring of classical and newer anticonvulsants;Therapeutic Drug Monitoring;2024
2. Black-Box Warnings of Antiseizure Medications: What is Inside the Box?;Pharmaceutical Medicine;2023-04-29
3. Second Generation of Antiepileptic Drugs and Oxidative Stress;International Journal of Molecular Sciences;2023-02-15
4. Felbamate add-on therapy for drug-resistant focal epilepsy;Cochrane Database of Systematic Reviews;2022-08-01
5. Anti-convulsant Agents: Felbamate;NeuroPsychopharmacotherapy;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3